🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ameliorated Pap Tests and Cervical Cancer Screening Participation

RecruitingNAAges 25 Years - anyFemaleNational Taiwan University Hospital
NCT06968871 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Pap test plays a crucial role in the early detection of cervical cancer. A pilot single-center randomized controlled trial applied the peak-end concept and added a non-painful step at the end of Pap smear screening, aimed to reduce recalled pain. However, there is still no multicenter study investigating the effect of the modified Pap test on cervical cancer screening participation. The present project is the first multicenter randomized controlled trial to expand the current scope of the peak-end theory into Pap tests and cervical cancer screening participation by adding a non-painful step at the end of Pap smear screening. Our multidisciplinary team (NTUH Pap Study Group) aims to provide innovative, feasible, and low-cost strategies for cervical cancer screening participation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women aged 25 or above Exclusion Criteria: * Ongoing menstruation * Pregnancy * Incapability of understanding the numeric pain scales * Any active cancer at study entry (defined as cancer diagnosed or treated within the previous 6 months, recurrent, regionally advanced or metastatic cancer) * Previous hysterectomy, pelvic surgery, or radiotherapy * Active vaginal or uterus infection * Analgesic use within 24 hours
💊

What it tests

  • Modified Pap test
📍

Where

5 sites
National Taiwan University Hospital Yunlin Branch
Douliu, Taiwan
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
National Taiwan University Cancer Center
Taipei, Taiwan
National Taiwan University Hospital Beihu Branch
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy